FAST vs KALA · P/E 43, rev $4.59B vs $54.3M cap
Fastenal Company (FAST) versus Kala Pharmaceuticals Inc (KALA) — a side-by-side from cached financials, not a winner call.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Kala Pharmaceuticals Inc (KALA) is a biotechnology company listed on NASDAQ.
Latest reported FAST revenue for 2026-06-30 was $4.59B. Net income was $722.6M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Latest reported KALA revenue for 2025-12-31 was $0. Net income was -$27.0M. KALA currently screens at market cap $54.3M.
FAST currently screens at market cap $49.48B and trailing P/E 43.1. KALA currently screens at market cap $54.3M.
Not investment advice. Open the FAST and KALA stock pages for the full models.
Not investment advice.